Jagged-2, a signaling protein, may be a potential therapeutic target for slowing or halting the progression of PAH, according ...

Two Phase 3 clinical trials testing the experimental therapy TNX-103 in people with PH-HFpEF are currently recruiting ...

Uptravi may reduce blood pressure in the lungs of children with pulmonary arterial hypertension, according to a meta-analysis ...

Columnist Mike Naple would rather be focusing on baking utensils this holiday season, but living with PH requires multiple ...

A committee has recommended an expansion of the indication for Winrevair, an approved injection therapy for adults with PAH, ...

Columnist Jen Cueva thought she had the flu, but it turned out to be much more serious. She says that with PH, life often gives you lemons.

The FDA approved a Phase 2b trial of CS1, a new PAH therapy being tested for its impact on lung vessel resistance and exercise capacity.

Scientists found altered activity of the PUM1 protein plays a key role in pulmonary hypertension development, making it a PH treatment target.

Having more severe chronic lung disease does not predict worse pulmonary hypertension outcomes in infants born preterm, a new ...

Pulmonary hypertension (PH) is a rare, life-threatening disease that affects the pulmonary arteries, the lungs, and the heart. Patients who suffer from the disease have narrow and obstructed pulmonary ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...